English: Dr. Willy Aspinall Aspinall & Associates Beaconsfield, UK Dr. David Asher Chief, Laboratory of Bacterial, Parasitic and Unconventional Agents Division of Emerging and Transfusion Transmitted Diseases Office of Blood Research and Review CBER United States Food and Drug Administration Prof. Herbert Budka Professor of Neuropathology, Institute Director Institute of Neurology University of Vienna, Austria Dr. Neil Cashman Professor and Canada Research Chair, Brain Research Centre Dept of Medicine (Neurology), UBC Scientific Director, PrioNet Canada Dr. Philip Comer Business Leader DNV Consulting Det Norske Veritas, London Dr. Katy Davison NBS/HPA Senior Infection Surveillance Officer Health Protection Agency, London Dr. Gilles Delage Vice-President, Medical Affairs-Microbiology Héma-Québec, Canada Dr. Albert Farrugia Head, Blood and Tissues Unit Office of Devices, Blood and Tissues Therapeutic Goods Administration Woden, Australia Dr. Tini Garske Research Fellow, Institute for Mathematical Sciences Department of Infectious Disease Epidemiology Imperial College, London Dr. Mindi Goldman Executive medical Director Canadian Blood Services Dr. Paul Gully World Health Organization (WHO) Geneva, Switzerland Dr. Gerard Jansen National Laboratory for Host Genetics & Prion Diseases Canada CJD Surveillance System National Microbiology Laboratories Public Health Agency of Canada Dr. Nilima Justice Product Safety Senior Director Novo Nordisk, Denmark Dr. Gerarld Klein Chief Medical Officer and VP Medical and Scientific Affairs Talecris Biotherapeutics Canada Dr. Daniel Krewski Professor and Director, McLaughlin Centre for Population Health Risk Assessment University of Ottawa Robert Mayne Blueprints of the Future Ottawa, Canada Dr. Jean Michaud Professor and Chair, Department of Pathology and Laboratory Medicine Faculty of Medicine University of Ottawa Canada Dr. Luc Noel Project Leader, Vigilances/Transplantation Health Technology and Pharmaceuticals Cluster Office of the Executive Director World Health Organization (WHO) Geneva, Switzerland Dr. Ana Padilla Essential Health Technologies World Health Organization (WHO) Geneva, Switzerland Dr. Maurizio Pocchiari Department of Cell Biology and Neurosciences Istituto Superiore di Sanità Rome, Italy Dr. Pierre Robillard Héma-Québec Canada Dr. Robert Rohwer Director, Molecular Neurovirology Unit Veterans Affairs Medical Center Assoc. Professor of Neurology, School of Medicine University of maryland at Baltimore US Kitamoto Tetsuyuki Professor and Chariman, Department of Neurological Science Tohoku University School of Medicine Sendai, Japan Dr. Cees L. Van der Poel Secretary ,Medical Affairs Sanquin Blood Supply Foundation Amsterdam Professor Robert will Professor of Clinical Neurlogy University of Edinburgh UK Mark A. Vimr Vice-President Clinical Operations and Chief Nursing Officer Trillium Gift of Life Network Canada Finally, we would like to extend an enormous thank you to all of the sponsors for their generous support:
French: Dr. Willy Aspinall AAspinall & Associates Beaconsfield, Royaume-Uni Dr. David Asher Director, Laboratory of Bacterial, Parasitic and Unconventional Agents Division of Emerging and Transfusion Transmitted Diseases Office of Blood Research and Review CBER United States Food and Drug Administration &Ecute;tats-Unis Prof. Herbert Budka Professeur de Neuropathologie, Directeur d'Institut Bureau coordonnateur de l’UE Universitat of Wien Autriche Dr. Neil Cashman Professeur et président de recherche du Canada Centre de recherche Cérébral Faculté de médecine (Neurologie), UBC Directeur scientifique, PrioNet Canada Dr. Philip Comer Directeur DNV Consulting Det Norske Veritas Londres R.-U. Dr. Katy Davison Agent principal de surveillance des infections NBS/HPA Health Protection Agency Londres, R.-U. Dr. Gilles Delage Vice-Président, Affaire Médicale - Microbiologie Héma-Québec Canada Dr. Albert Farrugia Directeur, Blood and Tissues Unit Office of Devices, Blood and Tissues Therapeutic Goods Administration Woden, Australie Dr. Tini Garske Chercheure, Institute for Mathematical Sciences et Department of Infectious Disease Epidemiology Epidemiology Imperial College Londres, R.-U. Dr. Mindy Goldman Directrice générale des services médicaux Société canadienne du sang Canada Dr. Paul Gully Conseiller principal chargé des maladies transmissibles Organisation mondiale de la Santé (OMS) Genève, Suisse Dr. Gerard Jansen Programme de génétique de l'hôte et des maladies à prion Système de surveillance de la MCJ au Canada Laboratoire national de microbiologie Agence de la santé publique du Canada Dr. Nilima Justice Directrice principale, Sécurité des produits Novo Nordisk, Danemark Dr. Gerarld Klein Directeur des services médicaux et vice-président Affaires médicales et scientifiques Talecris Biotherapeutics Canada Dr. Daniel Krewski Professeur et directeur Centre McLaughlin d’évaluation du risque pour la santé des populations Université d’Ottawa Robert Mayne Blueprints of the Future Ottawa, Canada Dr. Jean Michaud Professeur et président, Département de pathologie et médecine de laboratoire Faculté de médecine Université d'Ottawa Canada Dr. Luc Noel Coordonnateur, Procédures cliniques RPC/ESE Organisation Mondiale de la santé (OMS) Genève, Suisse Dr. Ana Padilla Technologies essentielles de la santé Organisation Mondiale de la santé(OMS) Genève, Suisse Dr. Maurizio Pocchiari Département de biologie cellulaire et des neurosciences Istituto Superiore di Sanità Rome, Italie Dr. Pierre Robillard Héma-Québec Canada Dr. Robert Rohwer Directeur, Unité de neurovirologie moléculaire VVA Medical Center Professeur agrégé à la School of Medicine University of Maryland at Baltimore Dr. Kitamoto Tetsuyuki Professeur et directeur, Département des sciences neurologiques Faculté de médecine de l’université Tohoku Sendai, Japon Dr. Cees L. Van der Poel Secrétaire, Affaires médicales Fondation des services sanguins, sanquins Amsterdam, Pays-Bas Professeur Robert will Professeur Clinique Neurologie Université d'Edimbourg R.-U. Mark A. Vimr Vice-président, Services cliniques, et directeur, services infirmiers Réseau Trillium pour le don de vie Canada Finalement, Nous voudrions adresser nos sincères remerciement à tous les commanditaires pour leur appui généreux: